Sponsor or institution

Clinical trials and research at Forward Pharmaceuticals Co., Ltd.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Combining FWD1802 with CDK4/6 inhibitors or everolimus for ER+/HER2- advanced breast cancer

  This trial tests whether adding FWD1802 to CDK4/6 inhibitors or everolimus helps people with ER-positive/HER2-negative unresectable locally advanced or metastatic breast cancer who have progressed on or cannot use standard therapy.

  Recruiting Phase 1/2 Forward Pharmaceuticals Co., Ltd. · Shanghai · NCT07002177

• Testing FWD1802 for ER+/HER2- breast cancer

  This study is testing a new treatment called FWD1802, alone and with another drug, to see if it can help people with advanced ER+/HER2- breast cancer feel better and improve their outcomes.

  Recruiting at 20 sites Phase 1/2 Forward Pharmaceuticals Co., Ltd. · Hefei, Anhui and 21 other locations · NCT06064812

Quick answers

How many clinical trials run by Forward Pharmaceuticals Co., Ltd. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →